Development of dna probes and immunological reagents of human tumor associated antigens
Abstract
(-- A summary 57) The method of manufacturing the immunological reagent as for which * carries out the cell surface antigen of the (correction -- owner) subject human origin is offered. Solution means DNA as for which * carries out the character which can be identified so that DNA isolated from human tumor cells and selection are possible is introduced into the established non-human tumor formative-cells system, Choose and collect transduced cells and this is poured into the 1st suitable rat host, The poured-in transduced cell is induced and the obtained rat host is maintained during the period effective in forming a tumor in a rat host, Obtain tumor cells from the obtained tumor, solid-phase-ize the antiserum generated to that tumor cell to the non-human non-tumor formative-cells system established above-mentioned, pour an antiserum solid phase-ized cell into the 2nd suitable host, and this host is screened, Extraction and hype ーマ are adjusted for a spleen from the 2nd host who identified the host who generates the serum reacted to human tumor cells, and was identified by making it such, and the hype ーマ cell lines which produce the antibody which recognizes a cell surface antigen specifically and is combined are collected.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
42 members in 8 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 60380490 | United States of America | A | |
| 9107912 | United States of America | W |
Members42
| Document | Office | Kind | |
|---|---|---|---|
| CA2094378A1 | Canada | A1 | |
| WO9208131A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8931491A | Australia | A | |
| JPH06505147A | Japan | A | |
| EP0641385A4 | European Patent Office (EPO) | A4 | |
| EP0641385A1 | European Patent Office (EPO) | A1 | |
| AU660001B2 | Australia | B2 | |
| CA2209941A1 | Canada | A1 | |
| WO9621671A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4751196A | Australia | A | |
| EP0804458A1 | European Patent Office (EPO) | A1 | |
| WO9810098A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4182697A | Australia | A | |
| US5851764A | United States of America | A | |
| JPH11502404A | Japan | A | |
| AU709056B2 | Australia | B2 | |
| EP0951567A1 | European Patent Office (EPO) | A1 | |
| US6159751A | United States of America | A | |
| US6184032B1 | United States of America | B1 | |
| US2001014474A1 | United States of America | A1 | |
| JP2001292767A | Japan | A | |
| JP3256227B2 | Japan | B2 | |
| JP2002159293A | Japan | A | |
| EP0804458A4 | European Patent Office (EPO) | A4 | |
| EP0951567A4 | European Patent Office (EPO) | A4 | |
| US2002155437A1 | United States of America | A1 | |
| EP0641385B1 | European Patent Office (EPO) | B1 | |
| AT230024TThis record | Austria | T | |
| ATE230024T1 | Austria | T1 | |
| DE69133185D1 | Germany | D1 | |
| JP3376357B2 | Japan | B2 | |
| JP3445586B2 | Japan | B2 | |
| US2004203063A1 | United States of America | A1 | |
| US6811972B1 | United States of America | B1 | |
| US6869760B2 | United States of America | B2 | |
| US2005163709A1 | United States of America | A1 | |
| US2005250206A1 | United States of America | A1 | |
| EP0951567B1 | European Patent Office (EPO) | B1 | |
| AT330028T | Austria | T | |
| ATE330028T1 | Austria | T1 | |
| DE69736122D1 | Germany | D1 | |
| DE69736122T2 | Germany | T2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 92909591
Titles2
- German
- ENTWICKLUNG VON DNS-SONDEN UND IMMUNOLOGISCHEN REAGENZIEN VON MENSCHLICHEN TUMOR-ASSOZIIERTEN ANTIGENEN
- English
- DEVELOPMENT OF DNA PROBLEMS AND IMMUNOLOGICAL REAGENTS OF HUMAN TUMOR ASSOCIATED ANTIGENES
Classification
- CPC, 9
- C07K16/28
- A61K38/00
- A61P35/00
- C07K14/82
- C07K16/30
- C07K16/3069
- C07K16/32
- C12Q1/6886
- C12Q2600/112
- IPC, 22
- A61K38 00
- A61K39 395
- A61P35 00
- C07K14 705
- C07K14 82
- C07K16 28
- C07K16 30
- C07K16 32
- C07K19 00
- C12N15 02
- C12N15 08
- C12N15 09
- C12N5 10
- C12N5 18
- C12P21 08
- C12Q1 68
- C12R1 91
- G01N33 50
- G01N33 53
- G01N33 566
- G01N33 574
- G01N33 577